Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Annovis Bio Inc (ANVS)

Annovis Bio Inc (ANVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,053
  • Shares Outstanding, K 6,892
  • Annual Sales, $ 0 K
  • Annual Income, $ -990 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.53
Trade ANVS with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.85 +71.28%
on 12/16/20
10.50 -4.57%
on 01/14/21
+4.02 (+67.09%)
since 12/15/20
3-Month
4.14 +142.03%
on 11/02/20
10.50 -4.57%
on 01/14/21
+5.06 (+102.01%)
since 10/15/20

Most Recent Stories

More News
Annovis Bio to Present at H.C. Wainwright BioConnect 2021 Conference

Berwyn, Pennsylvania--(Newsfile Corp. - January 5, 2021) -  Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other...

ANVS : 10.02 (-0.10%)
Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report

Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced an interview...

ANVS : 10.02 (-0.10%)
LD Micro - 360 Companies Set to Present this Week

LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACRX : 2.08 (+11.83%)
ACER : 3.85 (+34.62%)
ACU : 31.58 (-4.01%)
AT.VN : 1.610 (-0.62%)
AEY : 2.74 (-1.44%)
ADIL : 1.9200 (-6.80%)
ADTX : 2.37 (-4.05%)
ADXS : 0.6100 (-4.06%)
AEHR : 2.14 (-0.47%)
AIM : 2.04 (+0.99%)
AIRI : 1.5300 (+0.66%)
ALIM : 6.60 (+12.44%)
ALJJ : 1.2300 (-10.22%)
ALLT : 13.55 (-8.45%)
ARCT : 59.69 (-4.14%)
AREC : 2.06 (-6.36%)
AMS : 2.33 (+0.43%)
ANVS : 10.02 (-0.10%)
APEN : 3.90 (+3.17%)
APM : 3.31 (+16.14%)
AQMS : 3.72 (-1.33%)
AQB : 11.00 (-3.17%)
ARTL : 0.9699 (-3.97%)
ARHH : 1.1700 (unch)
ATOM : 28.66 (-6.34%)
ATOS : 1.2500 (unch)
AUTO : 2.59 (-5.82%)
AYRO : 6.66 (-6.06%)
AZRX : 0.8700 (-2.25%)
BELFA : 15.25 (+3.60%)
BCDA : 3.83 (+2.13%)
BIOC : 5.36 (-2.19%)
BHTG : 1.4400 (-2.70%)
BIOL : 0.8330 (-8.87%)
BKEP : 2.02 (unch)
ATDS : 0.0085 (+1.19%)
ASUR : 7.42 (+0.13%)
BEER.VN : 0.115 (+4.55%)
ANY : 2.07 (-5.91%)
Annovis Bio to Present at The LD 500 Virtual Conference

LOS ANGELES, CA / ACCESSWIRE / August 25, 2020 / Annovis Bio Inc. (NYSE American:ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative...

ANVS : 10.02 (-0.10%)
LD Micro Announces Preliminary List of Presenters for the LD 500

LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACER : 3.85 (+34.62%)
ACU : 31.58 (-4.01%)
AEY : 2.74 (-1.44%)
ADIL : 1.9200 (-6.80%)
ADXS : 0.6100 (-4.06%)
AEHR : 2.14 (-0.47%)
AIM : 2.04 (+0.99%)
AIRI : 1.5300 (+0.66%)
KERN : 6.34 (-3.21%)
ALIM : 6.60 (+12.44%)
ALLT : 13.55 (-8.45%)
AMS : 2.33 (+0.43%)
ANVS : 10.02 (-0.10%)
APEN : 3.90 (+3.17%)
APM : 3.31 (+16.14%)
AQB : 11.00 (-3.17%)
ARTL : 0.9699 (-3.97%)
ARHH : 1.1700 (unch)
ATOM : 28.66 (-6.34%)
ATOS : 1.2500 (unch)
ACU.VN : 0.350 (+4.48%)
AUTO : 2.59 (-5.82%)
AYRO : 6.66 (-6.06%)
AYTU : 7.44 (+0.68%)
AZRX : 0.8700 (-2.25%)
BLDP : 30.83 (-10.78%)
BELFA : 15.25 (+3.60%)
BCDA : 3.83 (+2.13%)
BIOC : 5.36 (-2.19%)
BMRA : 5.70 (-5.94%)
BSGM : 4.82 (-8.71%)
BLNK : 47.10 (-10.49%)
BKEP : 2.02 (unch)
CLBS : 1.5700 (+0.64%)
CLXT : 6.07 (+20.34%)
ASUR : 7.42 (+0.13%)
BLGO : 0.1365 (-3.26%)
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th

The Virtual Summer Summit will take place on June 9-12, connecting 47 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below...

ACCO : 8.83 (-0.11%)
ALIM : 6.60 (+12.44%)
ANVS : 10.02 (-0.10%)
AQB : 11.00 (-3.17%)
ARTL : 0.9699 (-3.97%)
AVLNF : 0.1126 (-2.00%)
BLCM : 3.65 (-3.95%)
NDRA : 1.0500 (+3.96%)
EFOI : 4.81 (-4.94%)
EQ : 5.20 (-1.52%)
EXROF : 3.0710 (-5.22%)
HL : 5.31 (-9.23%)
HSII : 32.78 (-0.52%)
HSDT : 15.42 (+0.06%)
HGBL : 2.98 (-4.79%)
IPWR : 9.00 (+4.05%)
LINC : 6.24 (+0.16%)
MBII : 1.5300 (+13.33%)
MLSS : 2.76 (+4.94%)
MYSZ : 1.3600 (-6.21%)
NBEV : 2.97 (-1.33%)
ONCS : 6.26 (-1.11%)
OGEN : 0.9287 (-2.24%)
SFE : 6.59 (+0.92%)
SLS : 6.01 (-0.66%)
PIXY : 2.70 (-4.93%)
SGLB : 3.66 (-13.68%)
SOTK : 4.4500 (-1.55%)
TNXP : 0.9100 (-4.85%)
TGA : 1.1700 (-0.85%)
URG : 1.0700 (-10.08%)
Annovis Bio to Present at the Online Spring Investor Summit on March 25

NEW YORK, NY / ACCESSWIRE / March 19, 2020 / Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's, Parkinson's and other neurodegenerative diseases, is...

ANVS : 10.02 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.

See More

Key Turning Points

3rd Resistance Point 11.36
2nd Resistance Point 10.93
1st Resistance Point 10.47
Last Price 10.02
1st Support Level 9.58
2nd Support Level 9.15
3rd Support Level 8.69

See More

52-Week High 10.61
Last Price 10.02
Fibonacci 61.8% 7.48
Fibonacci 50% 6.51
Fibonacci 38.2% 5.55
52-Week Low 2.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar